H. Gendelman

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Howard E. Gendelman, Howard e. Gendelman, H. Gendelman, H E Gendelman, H. E. Gendelman, Howard Gendelman, H Gendelman, Howard E Gendelman, Howard Eliot Gendelman
Publication record
660 papers · 40,299 citations · H-index 103

PAPERS

Colostrum extracellular vesicles are neuroprotective in models of Parkinson's disease
20260 citationsauthor #20
Searching for a HIV-1 Cure
20261 citationsauthor #10
CAR Treg Therapies for Neurodegenerative Diseases
20260 citationsauthor #2
Adaptive immunity in the pathogenesis and treatments of Parkinson’s disease
20252 citationsauthor #6
Bioactive polymers as stimulus-responsive anti-metastatic combination agents to treat pancreatic cancer.
20250 citationsauthor #9
Extracellular vesicle-based therapies for neurodegenerative diseases
20250 citationsauthor #5
The 29th Scientific Conference of the Society on NeuroImmune Pharmacology in Omaha, NE, June 8–12, 2025
20250 citationsauthor #9
Amyloid precursor protein and presenilin‐1 knock‐in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss
20258 citationsauthor #13
CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses
20253 citationsauthor #13
The promise and perils of humanized mice: workshop report from the 29th scientific conference of the society on NeuroImmune pharmacology (SNIP)
20250 citationsauthor #3
HIV-1 infection facilitates Alzheimer’s disease pathology in humanized APP knock-in immunodeficient mice
20252 citationsauthor #11
Innate Immunity and Parkinson's Disease.
20250 citationsauthor #6
CEST MRI detects antiretroviral drug toxicities in the developing mouse brain
20250 citationsauthor #10
Neuroprotective mushrooms
20243 citationsauthor #4
Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice
20244 citationsauthor #6
Theranostic Diagnostics.
20241 citationsauthor #4
Polymer Delivery Systems for Long-Acting Antiretroviral Drugs
20249 citationsauthor #7
CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities
20240 citationsauthor #1
Development of an extended action fostemsavir lipid nanoparticle
20244 citationsauthor #8
Correction: Specific transfection of inflamed brain by macrophages: A new therapeutic strategy for neurodegenerative diseases
20240 citationsauthor #11
Immune senescence in aged APP/PS1 mice
20235 citationsauthor #10
Abstracts of the 19th International Symposium on NeuroVirology October 2–5, 2023 Montreal, Quebec, Canada
20232 citationsauthor #126
Clinical biomarkers for Lewy body diseases
202311 citationsauthor #7
An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
202321 citationsauthor #8
Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model
20238 citationsauthor #9
Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection.
202333 citationsauthor #10
Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice
202344 citationsauthor #13
Development of a porous layer-by-layer microsphere with Development of a porous layer-by-layer microsphere with branched aliphatic hydrocarbon porogens branched aliphatic hydrocarbon porogens
20230 citationsauthor #11
Humanized Mice for Studies of HIV-1 Persistence and Elimination
202317 citationsauthor #5
CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice
202353 citationsauthor #22
Delivery of gene editing therapeutics.
20237 citationsauthor #22
Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors
20235 citationsauthor #5
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
202212 citationsauthor #8
Dual-Peak Lorentzian CEST MRI for antiretroviral drug brain distribution
20222 citationsauthor #3
Oral antivirals for the prevention and treatment of SARS-CoV-2 infection.
202220 citationsauthor #7
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy.
20225 citationsauthor #5
Development of an extended half-life GM-CSF fusion protein for Parkinson's disease.
202229 citationsauthor #9
Prodrug Therapies for Infectious and Neurodegenerative Diseases
20226 citationsauthor #8
Animal models for studies of HIV‐1 brain reservoirs
202216 citationsauthor #6
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
202212 citationsauthor #7
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
202232 citationsauthor #23
Development of a porous layer-by-layer microsphere with branched aliphatic hydrocarbon porogens.
20221 citationsauthor #11
Pathways for Dolutegravir Transformation from a Daily Oral to a Once-a-Year Parenteral Medicine
20220 citationsauthor #20
Multipolymer microsphere delivery of SARS-CoV-2 antigens
202212 citationsauthor #14
Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases.
20225 citationsauthor #7
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
202210 citationsauthor #11
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
202217 citationsauthor #2
The Potential for Treg-Enhancing Therapies in Nervous System Pathologies.
202241 citationsauthor #3
Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis.
202229 citationsauthor #14
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
202222 citationsauthor #4
Introducing NeuroImmune Pharmacology and Therapeutics (NIPT), the official journal of the Society on NeuroImmune Pharmacology (SNIP)
20220 citationsauthor #2
The 2022 outbreak and the pathobiology of the monkeypox virus
2022407 citationsauthor #3
CD4+ effector T cells accelerate Alzheimer’s disease in mice
2021108 citationsauthor #20
The Immunopathobiology of SARS-CoV-2 Infection
202110 citationsauthor #16
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
202139 citationsauthor #10
The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings
20211 citationsauthor #4
CD4+ effector T cells accelerate Alzheimer’s disease in mice
20216 citationsauthor #20
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
202138 citationsauthor #13
Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs
20214 citationsauthor #12
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
202135 citationsauthor #13
Exonic Disruption Facilitates Antiviral CRISPR-Cas9 Activity for Multistrain HIV-1 Elimination
20211 citationsauthor #12
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
202117 citationsauthor #7
Nanocarrier vaccines for SARS-CoV-2
202174 citationsauthor #26
Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment
202120 citationsauthor #5
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
202136 citationsauthor #26
Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions
20216 citationsauthor #12
CD4+ T cell effector activities accelerate Alzheimer’s disease pathologies
20210 citationsauthor #5
Humanized Mice for Infectious and Neurodegenerative disorders
202123 citationsauthor #14
Humanized Mice for Infectious and Neurodegenerative disorders
20210 citationsauthor #14
Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease.
202138 citationsauthor #14
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
20210 citationsauthor #26
EFAVIRENZ, ATAZANAVIR, AND RITONAVIR DISRUPT SARCOPLASMIC RETICULUM Ca2+ HOMEOSTASIS IN SKELETAL MUSCLES.
20214 citationsauthor #5
A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection
20215 citationsauthor #9
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
202135 citationsauthor #12
"Exonic Disruption Facilitates Antiviral CRISPR-Cas9 Activity for Multistrain HIV-1 Elimination" data files
20210 citationsauthor #3
Diagnostics for SARS-CoV-2 infections
2021701 citationsauthor #20
CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination
202144 citationsauthor #11
Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue
20217 citationsauthor #2
Pharmacotherapeutics of SARS-CoV-2 Infections
20216 citationsauthor #20
Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice
202112 citationsauthor #9
Pathways towards human immunodeficiency virus elimination
202017 citationsauthor #5
Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues
202029 citationsauthor #18
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
2020493 citationsauthor #14
Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons
2020223 citationsauthor #13
Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice
202010 citationsauthor #7
A Year-Long Extended Release Nanoformulated Cabotegravir Prodrug
202089 citationsauthor #21
Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases
20202 citationsauthor #3
Immunotherapy for Parkinson’s disease
202063 citationsauthor #6
Elucidating the pathogenic mechanisms of AD brain‐derived, tau‐containing extracellular vesicles: Highly transmissible and preferential propagation to GABAergic neurons
20202 citationsauthor #7
SARS-CoV-2 Infection Leads to Neurological Dysfunction
202087 citationsauthor #3
SARS-CoV-2 Infection Leads to Neurological Dysfunction
20201 citationsauthor #3
Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice
202026 citationsauthor #11
HIV-1-Associated Left Ventricular Cardiac Dysfunction in Humanized Mice
20209 citationsauthor #7
HIV-1-Associated Left Ventricular Cardiac Dysfunction in Humanized Mice
20200 citationsauthor #7
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
20208 citationsauthor #7
Alzheimer’s disease brain-derived tau-containing extracellular vesicles: Pathobiology and GABAergic neuronal transmission
20200 citationsauthor #12
A long-acting 3TC ProTide nanoformulation suppresses HBV replication in humanized mice.
202017 citationsauthor #8
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
2020111 citationsauthor #8
JNIP Impact Factor Rise Is a Final Tribute to the Years of Impactful Service Made by our Managing Editor
20200 citationsauthor #1
Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking.
201921 citationsauthor #14

TIMELINE

1983 95 citations

1984 125 citations

1985 604 citations

1986 2,837 citations

1987 42 citations

1988 358 citations

1990 722 citations

1991 223 citations

1992 753 citations

1993 443 citations

1994 1,327 citations

1995 1,409 citations

1996 912 citations

1997 685 citations

1998 683 citations

1999 1,089 citations

2000 548 citations

2001 551 citations

2002 590 citations

2003 863 citations

2004 887 citations

2005 1,401 citations

2006 1,736 citations

2007 3,471 citations

2008 1,263 citations

2009 2,067 citations

2010 1,636 citations

2011 1,711 citations

2012 2,533 citations

2013 805 citations

2014 777 citations

2015 723 citations

2016 631 citations

2017 502 citations

2018 637 citations

2019 888 citations

2020 1,187 citations

2021 1,270 citations

2022 678 citations

2023 206 citations

2024 21 citations

2025 15 citations

2026 1 citations

Unknown 0 citations

H. Gendelman

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT